It has been reported that cardiolipin effectively triggers the activation of the NLRP3 inflammasome through an ROS-independent signaling pathway, contributing to the development of NASH (Peng et al., 2018; Ramos-Tovar and Muriel, 2023). The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatohepatitis.